| Date | Title | Description |
| 07.05.2024 | Prologue Medicines Raises $50M in Funding | Prologue Medicines, a Cambridge, MA-based company advancing therapeutics that leverage the viral proteome, received a $50m investment from Flagship Pioneering.
The company intends to use the funds to advance its Decoding Evolutionary Logic ... |
| 08.04.2024 | Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences | O'Shea is a Seasoned Global Executive with more than 20 Years' Experience across the Agriculture, Food and Pharmaceutical Industries
CAMBRIDGE, Mass., April 8, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, an... |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 20.03.2024 | Casper’s co-founder is helping launch an incubator for climate tech startups | Hundreds of climate-related startups have been founded in recent years, but for Casper co-founder Philip Krim, that’s not nearly enough.
“We need a lot more zero-to-one founders in this ecosystem,” he told TechCrunch. Relative to other indu... |
| 19.03.2024 | Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 | Ranked #3 Most Innovative Company in North America Recognized for the Third Consecutive Year
CAMBRIDGE, Mass., March 19, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigi... |
| 09.01.2024 | AI copilots and robo-labs turbocharge research | Laboratory "copilots" and automated labs are AI's latest contribution to speeding up the development of new drugs, chemicals and materials.
Why it matters: Scientific discovery itself must speed up if the world is to address its c... |
| 08.01.2024 | JPM24: Flagship chief says firm will have to ‘do some work’ before linking with China-based partners | Flagship went global last year, opening new offices in London and Singapore as part of a concerted expansion of the venture creation firm’s startup ecosystem. But it may be a bit before the Asia-Pacific outpost spurs new partnerships in Chi... |
| 08.11.2023 | Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore | André Andonian Joins Flagship to Lead APAC Region
SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced its expansion into the Asia-Pacific region, with the opening of a regional hu... |
| 02.11.2023 | Flagship Pioneering Launches Pioneering Intelligence | Flagship Pioneering launched Pioneering Intelligence, an initiative of Flagship Pioneering harnessing artificial intelligence (AI) to accelerate innovation in the life sciences and beyond. Flagship marked the official launch of Pioneering I... |
| 21.06.2023 | One of biotech’s biggest financiers launches small-molecule startup, in spite of IRA’s looming shadow | It’s been nearly a year since Congress passed the Inflation Reduction Act, raising a chorus of drug executive and investor complaints that it would decimate the development of small-molecule medicines. After all, it opens the door for Medic... |
| 10.01.2023 | The billionaire CEO of a top biotech VC firm details how a new type of AI could transform how we test and discover treatments | Flagship Pioneering CEO Noubar Afeyan. Flagship Pioneering
Artificial intelligence has the power to revolutionize biotech, Noubar Afeyan says.
Afeyan is the CEO and founder of Flagship Pioneering, the venture firm behind Moderna.
Flagship h... |
| 04.10.2022 | Flagship-founded Cellarity tacks on $121M series C to fund cell behaviour pipeline | Flagship-founded Cellarity has hauled in $121 million in new series C funds as the biotech continues to push its cell behavior therapies toward the clinic.
The latest financing round, announced Tuesday, brings the company’s total raised to ... |
| 27.05.2022 | Biotech Start-Up Finds Overlooked Proteins That Could Cure Diseases | If you were under the impression that our genome had about 20,000 genes, each a recipe for a different protein, you’re not alone. The Human Genome Project celebrated the first mapping of those 20,000 genes two decades ago.
But a new start-u... |
| 18.05.2022 | Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism | The SPDR S&P Biotech ETF (XBI), a key biotech index fund. (Google screenshot)
Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs.
But re... |
| 20.04.2022 | Agriland Inc. Farm Management & Realty Leverages CIBO Carbon Bridge Program to Support Transition to Regenerative Agriculture | "I am happy to partner with CIBO Carbon Bridge to begin generating carbon credits on my farm this year. CIBO understands the many challenges facing farmers and their adoption of regenerative practices,” said Patrick White, Agriland Inc... |
| 15.02.2022 | In a nail-biter, Rob Califf gets a second shot at FDA commissioner with Senate confirmation | Famed cardiologist, Duke University clinical trial researcher and former FDA commissioner Rob Califf won Senate confirmation for the second time on Tuesday, after more than a year without an appointed leader at the agency.
This time, after ... |
| 25.01.2022 | Flagship Pioneering Announces Appointment of Tom DiLenge as Senior Partner, Global Public Policy, Regulatory & Governmental Strategy | CAMBRIDGE, Mass., Jan. 25, 2022 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Tom DiLenge has joined the company in a newly created role as Senior Partner, Global Public Policy, Regulatory &am... |
| 24.01.2022 | CIBO Adds Grower and Consumer Packaged Goods Industry Expertise with New Senior Hires | “Michael and Travis bring critical knowledge and expertise to our leadership team that will help to maximize the impact and value we bring to CPG companies and growers.” said Daniel Ryan, chief executive officer at CIBO Technologies.
CAMBRI... |
| 14.01.2022 | 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter | The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies.
For a letter addres... |
| 14.01.2022 | 'Shots on goal' to 'deterministic' drug development: Flagship CEO, Moderna Chair Afeyan pens first annual letter | The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies.
Noubar Afeyan, Ph.D... |
| 07.12.2021 | Former FDA head Hahn takes helm of cancer blood test maker Harbinger Health | While many new medtech startups spend their first few years struggling to rack up enough capital and cachet to bring their ideas to fruition, Harbinger Health, which emerged from stealth just this week, already has both of those assets in s... |
| 07.12.2021 | Former FDA head Hahn takes helm of cancer blood test maker Harbinger Health | While many new medtech startups spend their first few years struggling to rack up enough capital and cachet to bring their ideas to fruition, Harbinger Health, which emerged from stealth just this week, already has both of those assets in s... |
| 07.12.2021 | Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test | CAMBRIDGE, Mass., Dec. 7, 2021 /PRNewswire/ -- Flagship Pioneering today announced the launch of Harbinger Health, a bioplatform company pioneering the detection of early cancer with a simple blood test that combines Artificial Intelligence... |
| 15.11.2021 | Flagship Pioneering Announces Appointment of Justine Levin-Allerhand as Senior Partner, Corporate Development | CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that Justine Levin-Allerhand, Ph.D., has joined the company in a newly created role as Senior Partner, Corporate Develo... |
| 09.11.2021 | CIBO Announces November 2021 County-Level Yield Forecasts for U.S. Crops | CIBO Announces November 2021 County-Level Yield Forecasts for U.S. Crops “We’re pleasantly surprised and hope a better than expected harvest could help provide stability when it comes to food prices," said Dustin Madison, agronomy cons... |
| 09.11.2021 | Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’ | On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, called Alltrna, will now focus on developin... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Democrats patted each other on the back for officially coalescing around a prescription drug plan that will let Medicare negotiate a limited set of drug prices, but analysts are already poking holes in the Dems’ plans and there’s a lot stil... |
| 03.11.2021 | Antios Therapeutics' hep B candidate gets another round of applause from investors, closing out a $171M megaround | Antios Therapeutics, the Atlanta biotech that was the brainchild of former hep C pioneer Pharmasset executive and former Antios CEO Abel De La Rosa, announced this morning that the biotech raised $75 million in a Series ... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Even while serving as the global R&D head for Teva several years ago, Michael Hayden had high hopes for a drug known as pridopidine. But he wasn’t always on the right track.
Researchers originally believed the drug, now the lead asset o... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Johnson & Johnson is looking for big ideas from small entrepreneurs. Spurred by the pandemic health inequities and ongoing racial injustice in local communities, J&J is running a new innovation challenge in six hard-hit cities. And ... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | ALS has proven to be one of the most challenging diseases for drug development, with only two approved medicines since the mid-1990s showing mild effects at slowing disease progression. Tuesday morning, another biotech attempting to create ... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Welcome to Endpoints MarketingRx, the new weekly about pharma marketing, advertising and drug commercialization.
The newsletter launch begs an old question though: what is pharma marketing and why does it matter?
To some people, pharma mark... |
| 03.11.2021 | Pioneering Medicines, An Initiative Of Flagship Pioneering, Establishes First-Of-Its-Kind Partnership With The Cystic Fibrosis Foundation To Develop Breakthrough Treatments For CF | CAMBRIDGE, Mass., Nov. 3, 2021 /PRNewswire/ -- Flagship Pioneering today announced a first-of-its-kind strategic partnership with the Cystic Fibrosis Foundation and Flagship's Pioneering Medicines to develop therapeutics that address the un... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | In its quest to deliver a new drug to treat major depressive disorder, Sage Therapeutics recently updated its Phase III study with a change analysts believe gives the biotech a better chance at FDA approval.
Sage altered... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | Only a few days after President Joe Biden seemed to signal that drug pricing reforms were left for dead, Democrats are already circulating plans for a scaled-back version of what they wanted initially, although with more limited Medicare ne... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | With NIBR chief Jay Bradner serving as the in-house expert on protein degradation, Novartis has its standards for the technology. A small transatlantic startup is clearly ready to meet them.
Dunad, a new player that emerged in the field in ... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | Moderna has always been thinking about how mRNA could transform the gene editing space, according to Eric Huang. In fact, they looked at it about a decade ago — but at the time, they were still a small, preclinical biotech, and technology l... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | When Chad Cowan was recruited to Harvard University 20 years ago to work on human embryonic stem cells, he was inspired by the idea that these specialized cells could be used to make insulin-producing beta cells and potentially cure Type 1 ... |
| 03.11.2021 | Covid-19 roundup: Eli Lilly withdraws mAbs from EMA review | The World Health Organization has granted Indian-produced Covid-19 vaccine emergency use listing, adding to its portfolio of acceptable vaccines.
A advisory group determined that Covaxin, produced by Indian drugm... |
| 03.11.2021 | Sage changes primary endpoint in key study months after analysts fret about depression drug's durability | If David Reese gets his way, Lumakras will be the first of many Amgen drugs that shatter the fences currently cordoning off vast swaths of protein targets as “undruggable.”
Lumakras, the groundbreaking KRAS G12C inhibitor 40 years in the ma... |
| 03.11.2021 | Bayer backs a George Church spinout trying to turn lab-invented amino acids into a new class of protein therapies | Six years ago, Daniel Mandell appeared on NPR to talk about an invention out of Jurassic Park.
As Crichton and Goldblum fans recall, International Genetic Technologies, Inc.’s contingency plan to make sure dinosaurs didn’... |
| 03.11.2021 | Can new drugs punch holes in cancer's protective barrier? For Parthenon Therapeutics, that's the $65M question | It’s probably not an exaggeration to say that all eyes in the marketing world are on Kate Cronin. Maybe not specifically on Cronin by name, but most definitely on the Moderna brand she is shepherding as the biotech’s first chief brand offic... |
| 03.11.2021 | PhaseBio claims positive PhII in platelet inhibition reversal; Trial software firm rebrands after hack, merger | Aiming to bring new cardiopulmonary drugs to market, PhaseBio took one step closer toward that goal Wednesday morning.
The biotech reported positive topline results for a Phase IIb study evaluating the drug bentracimab in ... |
| 02.11.2021 | Fresh off Kite and BeiGene deals, Shoreline ups the ante with a hefty crossover. But the biotech insists it's in no rush | Though it may seem like Shoreline Biosciences is rapidly gaining momentum with a flurry of deals — and, now, a new funding round — Kleanthis Xanthopoulos doesn’t feel he’s in a rush.
The biotech’s chief executive put the bow o... |
| 02.11.2021 | Leading proteomics player gets a trio of new partners; GV tries to prevent cervical cancer | A little over 6 months ago, John Baker got on a call from a CEO with a strange request.
Baker is head of innovation at Abcam, a British company that provides life science research tools to labs and companies around the world.... |
| 02.11.2021 | Covid-19 roundup: Pfizer raises 2021 vaccine sales forecast to $36B; Lilly lands $1.3B treatment deal with US government | Pfizer’s Covid-19 vaccine in 2021 is quickly becoming the best-selling medical product of all time in terms of annual sales.
The company on Tuesday reported its quarterly earnings and re-upped its yearly guidance on its ... |
| 02.11.2021 | FDA pushes back decision on J&J, Legend's BCMA CAR-T | Bristol Myers Squibb and bluebird can hold on to their status as the makers of the only approved BCMA CAR-T for a bit longer.
The FDA — which was scheduled to make a decision on Legend and J&J’s cilta-cel on Nov. 29 — has d... |
| 02.11.2021 | Pfizer reveals delays across the board for its clinical gene therapy programs | At JP Morgan 2020, a year after taking the reins at Pfizer, Albert Bourla claimed the company was poised to become a leader in gene therapy. He’s since thrown hundreds of millions of dollars at those plans, including a $630 m... |
| 26.10.2021 | BREAKING: Indigo Ag acquires Soil Metrics to boost carbon MRV capabilities | Indigo Ag has acquired Soil Metrics, a firm which carries out assessments of soil carbon sequestration, for an undisclosed sum.
The pair had already partnered on the acquirer’s Carbon by Indigo program, which works with farmers to generate ... |
| 21.10.2021 | BREAKING: CIBO Technologies raises $30m Series C funding for carbon trading tools | US carbon trading platform CIBO Technologies has raised $30 million in Series C funding, it said in a statement.
The Cambridge, Massachusetts-based company indicated that the funds will be used to boost the commercialization of its monitori... |
| 13.10.2021 | Analysis: how work is built in a startup studio | Analysis: how work is built in a startup studio |
| 13.10.2021 | Разбор: как строится работа в стартап-студии | Разбор: как строится работа в стартап-студии |
| 12.10.2021 | CIBO Announces October 2021 County-Level Yield Forecasts for U.S. Crops | “To combat these challenges, businesses and growers are looking to regenerative agriculture and other solutions to grow climate-resilient crops to help reduce costs and risk," said Brian Sutton, President and Founder of AirScout with f... |
| 29.09.2021 | Myths about startup studios | Myths about startup studios |
| 29.09.2021 | Мифы о работе стартап-студий | Мифы о работе стартап-студий |
| 15.09.2021 | Flagship Pioneering Announces Appointment of Kathy Biberstein as General Counsel | |
| 10.09.2021 | CIBO Announces September 2021 County-Level Yield Forecasts for U.S. Crops | “CIBO’s yield forecasts help farmers and other agricultural decision-makers have the up-to-the-minute information they need to understand how national yield and weather impacts come to life on their farms and in their local counties," ... |
| 19.08.2021 | CIBO Named “AI-based AgTech Company of the Year” In 2021 AgTech Breakthrough Awards Program | “This recognition from AgTech Breakthrough helps validate our path forward. CIBO will continue working towards real, measurable impact in sustainability,” said Daniel Ryan, CEO, CIBO.
CAMBRIDGE, Mass. and MINNEAPOLIS, Minn., (PRWEB) August ... |
| 16.08.2021 | CIBO Announces August 2021 County-Level Yield Forecasts for U.S. Crops | “Implementing regenerative agricultural practices helps us create climate resiliency in our fields," said Matt Leischner, Co-Owner of South Branch Farms. "Our focus on cover cropping, no-tillage, and smarter input selection helps ... |
| 28.07.2021 | Ring Therapeutics : Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy | CAMBRIDGE, Mass., July 28, 2021 /PRNewswire/ -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, announced today that it raised $117 million in Serie... |
| 14.06.2021 | Flagship Pioneering Completes $3.37 Billion Capital Pool | Flagship Pioneering, a Cambridge, Mass.-based bioplatform innovation company, announced an expansion of its capital base to support founding and growing its next generation of human health and sustainability companies.
Flagship re-opened Fu... |
| 14.06.2021 | Flagship Pioneering Closes $3.4 Billion Capital Pool to Drive Continued Breakthrough Innovations in Human Health and Sustainability | |
| 14.06.2021 | The broader implications of Lordstown’s failures | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
The boom in special purpose acquisition companies has helped some new-generation vehicle makers t... |
| 14.06.2021 | Brief: Flagship closes $3.4bn fund to build ‘bioplatform’ companies in ag, nutrition & health | Flagship Pioneering, the fund manager and company formation group, has closed its seventh fund on $3.4 billion after re-opening it to existing investors and a “select” group of new backers.
The close takes Flagship’s total assets under mana... |
| 25.05.2021 | BREAKING: Invaio raises $89m to accelerate commercialization of its injectable bio-inputs | Invaio Sciences has raised $88.9 million in a Series C round led by venture builder Flagship Pioneering, which launched the startup in 2018. Other investors joining the round include Stage 1 Ventures, Bluwave Capital, and Alexandria Venture... |
| 31.03.2021 | Flagship Pioneering : Expands Leadership Team with Appointment of Michael T. Nally as CEO-Partner | CAMBRIDGE, Mass., March 31, 2021 /PRNewswire/ -- Flagship Pioneering today announced the expansion of its senior leadership team with the appointment of Michael T. Nally as CEO-Partner. In this role, Nally will bring his considerable expert... |
| 31.03.2021 | Flagship Pioneering Expands Leadership Team with Appointment of Michael T. Nally as CEO-Partner | |
| 09.03.2021 | Could Valo Health become one of Flagship Pioneering’s biggest companies yet? | The investment firm Flagship Pioneering has incubated a lot of life sciences companies since it was founded in 2000. In fact, while a general partner with Flagship Pioneering over the last 15 years, David Berry has started more than 30 comp... |
| 12.02.2021 | Ex-Vividion chief Diego Miralles finds 'dream team' at stealthy Flagship portfolio company; Astellas looks inward to select CBO and CSO | Almost three months after leaving Vividion Therapeutics, where he recently signed a $135 million Roche deal, Diego Miralles has landed the top spot on a “dream team.”
On Thursday, Flagship Pioneering officially tapped M... |
| 11.02.2021 | Flagship names Miralles as latest CEO-partner | Diego Miralles, M.D., has joined Flagship Pioneering as CEO-partner. Flagship disclosed the appointment of Miralles, who will serve as CEO of its portfolio company Laronde, alongside news that it has hired ex-Rubius Therapeutics executive A... |
| 11.02.2021 | Flagship names Miralles as latest CEO-partner
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Diego Miralles, M.D., has joined Flagship Pioneering as CEO-partner. Flagship disclosed the appointment of Miralles, who will serve as CEO of its portfolio company Laronde, alongside news that it has hired ex-Rubius Therapeutics executive A... |
| 19.12.2020 | Meet Moderna’s cofounder and chairman, whose coronavirus vaccine is now approved on both sides of the Atlantic. He loves basketball and Dolly Parton. | Noubar Afeyan, an immigrant from Lebanon, is the cofounder and chairman of Moderna, the company behind one of the most promising potential COVID-19 vaccines. Flagship Pioneering
Noubar Afeyan is the cofounder and chairman of biotech firm Mo... |
| 16.11.2020 | From academia to both Mercks, Luciano Rossetti joins Flagship for his next act | Luciano Rossetti is checking all the boxes. After nearly two decades in academic medicine and almost as long leading R&D teams at Merck KGaA and Merck & Co., he’s jumping over to the venture world as Flagship Pioneering’s first chie... |
| 16.11.2020 | Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer | |
| 16.11.2020 | From academia to both Mercks, Luciano Rossetti joins Flagship for his next act | Luciano Rossetti is checking all the boxes. After nearly two decades in academic medicine and almost as long leading R&D teams at Merck KGaA and Merck & Co., he’s jumping over to the venture world as Flagship Pioneering’s first chie... |
| 29.10.2020 | Flagship launches Senda Biosciences with $88M in backing, looking to pioneer the field of 'Intersystems Biology' | Flagship Pioneering has a fresh company out this week, one that aims to lay the groundwork for a whole new discipline.
Senda Biosciences launched Wednesday with $88 million in Flagship cash. The goal? Gain insights into the ... |
| 05.08.2020 | Here’s how ‘five startups in one’ Indigo Ag plans to use its $360m Series F add-on | Indigo Ag has raised an additional $360 million in Series F financing on top of the $200 million injection it announced in January.
New and existing investors participated in the round including the Alaska Permanent Fund and Indigo’s first ... |
| 16.07.2020 | Единорог в пшеничном поле: стартап Indigo Agriculture меняет сельское хозяйство | Как стартап-студия за 5 лет вырастила компанию стоимостью $3,5 млрд и изменила правила игры в самой востребованной и изученной отрасли.
43 43 комментария
7707 просмотров
akamaihd.net
Всё начинается с микробиологии. В каждом растении содержа... |
| 27.04.2020 | Former Tesla and Lyft exec Jon McNeill just launched a fund that plans to spin out its own companies | Lyft’s former COO Jon McNeill has had a fairly storied career as an operator. A Northwestern University economics major who worked at Bain & Co. out of college, he went on to start and sell five companies before being introduced in 2015... |
| 02.04.2020 | ARCH Venture, Flagship Pioneering close funds worth nearly $2.6B | ARCH said it would use its two funds to invest in early-stage companies. Although it plans to frequently draw from both to invest in a single company, the overage fund will be used in fewer deals that require larger investments.
“ARCH is st... |
| 02.04.2020 | Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech | Flagship Pioneering, the Boston-based biotech incubator and holding company, said it has raised $1.1 billion for its Flagship Labs unit.
Flagship, which raised $1 billion back in 2019 for growth-stage investment vehicles, develops and opera... |
| 02.04.2020 | Flagship raises $1.1B to create biotechs for post-pandemic world | Flagship Pioneering has raised a $1.1 billion fund to create another batch of biotechs. The timing of the fund has Flagship peering into an uncertain future, trying to discern what opportunities will be attractive and impactful in the world... |
| 02.04.2020 | Flagship Pioneering Closes $1.1 Billion Capital Raise | Flagship Pioneering, a Cambridge, Mass.-based life sciences innovation enterprise, closed a $1.1 billion capital raise for its Flagship Pioneering Origination Fund VII.
The firm’s seventh origination fund will support the creation of Human ... |
| 02.04.2020 | Flagship raises $1.1B to create biotechs for post-pandemic world | Flagship Pioneering has raised a $1.1 billion fund to create another batch of biotechs. The timing of the fund has Flagship peering into an uncertain future, trying to discern what opportunities will be attractive and impactful in the world... |
| 13.03.2020 | Flagship combines two startups into cell therapy-focused Repertoire Immune Medicines | Torque and Cogen have raised a combined $220 million to date. In an emailed statement, Flagship noted that the majority of that funding was raised last year, led by Flagship and with several additional private investment groups participatin... |
| 08.04.2019 | Venture Capital In Q1 2019: The World Pulls Back From Record Highs
Money Out | 190 Shares Email Facebook Twitter LinkedIn
In venture, there are two tables, and VCs are the go-between.
There’s one where VCs listen to founders hawk their shares and make deals to gain purchase in growing companies, all for a cut of the e... |
| 08.04.2019 | Venture Capital In Q1 2019: The World Pulls Back From Record Highs
Money Out | 186 Shares Email Facebook Twitter LinkedIn
In venture, there are two tables, and VCs are the go-between.
There’s one where VCs listen to founders hawk their shares and make deals to gain purchase in growing companies, all for a cut of the e... |
| 20.03.2019 | Flagship Pioneering Secures $824M in New Capital Pool | Flagship Pioneering, a Cambridge, MA-based life sciences innovation enterprise, secured $824m in a new capital pool.
Special Opportunities Fund II will support the growth of human health and sustainability companies originated by its Flagsh... |
| 03.10.2018 | Flagship Pioneering GP Martinez: We’ve Benefitted from Mega-Mergers in Agriculture | Editor’s Note: Ignacio Martinez is general partner at Flagship Pioneering, the venture development organization (VDO) responsible for creating and incubating agtech’s best-funded startup, Indigo Agriculture. With a background in the healthc... |
| 09.08.2018 | Flagship’s Latest Venture Inari Raises $40m Series B to “Transform Plant Breeding” | Inari, the latest venture from venture development organization Flagship Pioneering, has raised $40 million in Series B funding.
The company describes itself as a plant breeding technology company aiming to “transform plant breeding to sign... |
| 09.08.2018 | Flagship’s latest venture Inari raises $40m Series B to ‘transform plant breeding’ | Inari, the latest venture from venture development organization Flagship Pioneering, has raised $40 million in Series B funding.
The company describes itself as a plant breeding technology company aiming to “transform plant breeding to sign... |
| 19.06.2018 | 15 Boston Microbiome Startups to Watch | “Bacteria, it’s the only culture some people have!”
If you spot someone wearing a tee shirt with that saying, there is some chance they work at a microbiome startup. If they don’t, it’s probably worth looking into.
The human microbiome is a... |
| 14.03.2018 | Flagship Pioneering Provides $50M to Foghorn Therapeutics | Flagship Pioneering, a unique life science innovation enterprise, today unveiled Foghorn Therapeutics. Foghorn uses its proprietary Gene Traffic Control™ product platform to discover and develop drugs based on novel insights into the chroma... |
| 02.02.2018 | Flagship Pioneering Announces Two Appointments | Flagship Pioneering, a Cambridge, MA-based life sciences innovation enterprise, appointed two new partners.
They are Rob Rosiello, executive partner and chief operating officer, and Jason Pontin, senior partner and chief editor.
Rob Rosiell... |
| 01.02.2018 | Flagship Pioneering Appoints Rob Rosiello and Jason Pontin | Flagship Pioneering, a life sciences innovation enterprise, continues to add expertise and talent to its senior leadership, today announcing the appointment of two new partners: Rob Rosiello, executive partner and chief operating officer, a... |
| 01.02.2018 | Flagship Pioneering Appoints Rob Rosiello and Jason Pontin | Flagship Pioneering, a life sciences innovation enterprise, continues to add expertise and talent to its senior leadership, today announcing the appointment of two new partners: Rob Rosiello, executive partner and chief operating officer, a... |
| 21.12.2017 | The Top 10 Farm Tech Deals of 2017 (How Many Can You Name Without Clicking?) | It was an exciting year in farm technology involving a few high profile venture capital exits and some of the largest deals on record.
In fact, funding records for this category and the subcategories within were broken more than once during... |
| 21.12.2017 | Flagship Pioneering Raises Further $618M | Flagship Pioneering, a Cambridge, MA-based life science innovation enterprise, secured $618m in new round of capital commitments.
This round, which includes commitments from long-time investors as well as many additional institutional inves... |
| 21.12.2017 | Flagship Pioneering forges ahead with $618M capital raise | Fourteen of Flagship Pioneering’s portfolio companies have gone public in the past four years. This month early stage biotech business Denali Therapeutics (NASDAQ: DNLI) and 10-year-old diagnostics company Quanterix (NASDAQ: QTRX) each did ... |
| 20.12.2017 | Term Sheet — Wednesday, December 20 | 5 Qs WITH A DEALMAKER
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Case, who is now the CEO and chairman of investment firm Revolution, teamed up with J.D. Vance, the author of “Hillbilly ... |
